Scott Dalgleish's most recent trade in Oncology Institute Inc (The) was a trade of 162,891 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncology Institute Inc (The) | Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 162,891 | 162,891 | - | - | Stock Option (right to buy) | |
Oncology Institute Inc (The) | Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 350,876 | 350,876 | - | - | Stock Options (right to buy) | |
Oncology Institute Inc (The) | Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 261,023 | 261,023 | - | - | Stock Options (right to buy) | |
Oncology Institute Inc (The) | Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 71,350 | 118,916 | - | 0 | Common Stock | |
Oncology Institute Inc (The) | Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 47,566 | 47,566 | - | 0 | Common Stock |